skip to navigation skip to content

pharmaceuticals

Investing in Cambridge drug discovery

PharmEnable raises £1.8 million for drug discovery expansion. PharmEnable, a venture supported by the Accelerate Cambridge programme at the Entrepreneurship Centre of Cambridge Judge Business School, said it has secured £1.8 million in a seed financing round led by Cambridge…

Read more

Petri dish.

Biotech vs big pharma

Most approved "priority" medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School. Biotech companies created 40 per cent more US Food & Drug Administration-approved "priority" drugs than…

Read more

Illustration of drug development.

Manhattan Project?

A "multiple-shots-on-goal" approach is needed to find coronavirus drugs, Cambridge Judge academics say in California Management Review. A many-shots-on-goal approach - not command and control - will most effectively develop vaccines and treatments for COVID-19 (coronavirus), Cambridge Judge Business School academics say in a new California Management Review article. Professor Christoph Loch While some have suggested…

Read more

Drug trials

An Executive MBA alumnus, Dr Rav Seeruthun, heads a Roche team that has developed a drug being tested to fight COVID-19.  Dr Rav Seeruthun (EMBA 2013) of Cambridge Judge Business School, is heading a team at the Roche UK Medical Directorate that has developed…

Read more

Picture of drug trials.

Growth recognition

Cambridge Healthcare Research, co-founded by Cambridge MBA alumnus Max Rubin (MBA 2010), awarded Queen's Award for Enterprise. Cambridge Healthcare Research Ltd, a firm whose Founding Partner is Cambridge MBA graduate Max Rubin (MBA 2010), was awarded a Queen's Award for…

Read more

Small gold cup and gold confetti.

Cambridge Executive MBA participants respond to the COVID-19 crisis

Participants in the 2019 cohort the Cambridge Executive MBA programme have implemented rapid changes within their respective organisations to respond to issues related to the COVID-19 (coronavirus) crisis. By considering how they can adapt organisational assets, utilise professional competencies and…

Read more

The entrance to the Phoenix Clinic.

Fast Company: How open-source medicine could prepare us for the next pandemic

A study on drug repurposing co-authored by Dr Nektarios Oraiopoulos, University Lecturer in Operations Management at Cambridge Judge Business School, is quoted in the article. The study found that “about 31 per cent of drugs approved by the FDA had…

Read more

Best first-day IPO

Cancer therapy company Monopar Therapeutics, led by Cambridge MBA Chandler Robinson, has very successful initial public offering (IPO) on Nasdaq. Monopar, a Chicago-based company seeking to improve clinical outcomes for cancer patients, led by Cambridge Judge Business School graduate Chandler…

Read more

Close up of lab assistant with sterile rubber gloves holding stand with test tubes with blood samples.

Pharma Voice: New pipeline pathways

Repurposing existing drugs could reduce cost and time when developing new medicine, but it’s not a straightforward approach. According to a study by Dr Nektarios Oraiopoulos, University Lecturer in Operations Management at Cambridge Judge, only two per cent of new…

Read more

Pharma journey

From Greece to Scotland Yard to providing drugs for clinical trials: Cambridge MBA alumna Vanessa Dekou (MBA 2002) built a global pharma business from scratch. Vanessa Dekou Cambridge MBA alumnus Vanessa Dekou re-mortgaged her London house to set up her…

Read more

Pile of blue, green and white pills.

Archives